Approximately 95% of NPC patients present mutations in NPC1 gene (MIM 607623; chr 18q11–q12) [2], [3], which encodes a membrane glycoprotein of 1,278 amino acids containing 13 transmembrane domains and localized in late endosomes. This evidence concerns the gene NPC1 and nasopharyngeal carcinoma.